Best Alzheimer's and Dementia Research Grants in Virgin Islands

Research institutions and organizations conducting Alzheimer’s and dementia-related research can access funding to run postbaccalaureate research education programs in the Virgin Islands and other U.S. territories. Grants from US Dept. of Health & Human Services: National Institutes of Health support intensive, mentored AD/ADRD research experiences for recent graduates, with up to US $400,000 available for program costs and development activities.

Virgin Islands dementia and Alzheimer’s organizations can access funding through the National Institutes of Health to run summer research education programs. Awards up to US $200,000 support hands-on AD/ADRD research experiences and enrichment activities for high school students, undergraduates, or science teachers, helping build the future Alzheimer’s and dementia research workforce.

Nonprofit research institutions and universities conducting translational Alzheimer’s and dementia studies in the Virgin Islands and other U.S. territories can apply for predoctoral fellowship support through the National Institutes of Health. These F31 awards fund diverse predoctoral trainees to build skills in AD/ADRD translational research, from population studies to work informing new treatments, diagnostics, and care.

Postdoctoral researchers from diverse backgrounds conducting translational Alzheimer’s and dementia research in the Virgin Islands can receive fellowship support for advanced training. US Dept. of Health & Human Services: National Institutes of Health supports projects ranging from population studies to work on new treatments, diagnostics, and behavioral or social aspects of AD/ADRD, excluding independently led clinical trials.

Undergraduate-focused U.S. institutions conducting biomedical research, including dementia and Alzheimer’s disease studies, can apply for National Institutes of Health AREA awards of up to US $375,000. Eligible colleges and universities in the Virgin Islands must grant baccalaureate science degrees and have limited prior NIH funding to support small-scale research and student training.

Researchers and academic institutions conducting aging, Alzheimer’s disease, or related dementias research can apply for the NIA Academic Leadership Career Award, with awards up to US $150,000, including in the Virgin Islands. Grants from US Dept. of Health & Human Services: National Institutes of Health help build institutional research capacity through infrastructure, mentorship, and career development activities without leading independent clinical trials.

Early-career translational researchers focused on Alzheimer’s and related dementias in the Virgin Islands can access funding via the National Institutes of Health to support a K99/R00 pathway to independence. Awards of approximately US $100,000 help investigators from diverse backgrounds build skills across population, behavioral, social, and treatment-focused AD/ADRD research without leading their own clinical trials.

Postdoctoral researchers from diverse backgrounds conducting Alzheimer’s and dementia research in the Virgin Islands can access funding through the National Institutes of Health to support their transition to independent faculty positions. Grants from NIH help build independent AD/ADRD research programs, including mentored clinical trial research experiences without leading an independent clinical trial.

Research institutions studying aging, Alzheimer’s disease, or related dementias in the Virgin Islands can apply for upcoming NIH R01 funding to investigate mechanisms linking olfactory decline with these conditions. This National Institute on Aging and NIDCD opportunity supports cellular, molecular, imaging, physiological, omics, and other approaches in older adults and/or animal models.

Researchers studying dementia and Alzheimer’s disease in the Virgin Islands can apply for National Institutes of Health support to investigate cerebellar roles in cognitive and affective function during aging and AD/ADRD. NIH provides funding for basic human or animal studies, secondary data analyses, and intervention-focused projects using the R01 activity code.

The BJA FY 2026 Kevin and Avonte Program aims to reduce the injuries and fatalities of individuals with dementia and developmental disabilities who wander from safe environments. This funding opportunity supports law enforcement and public safety agencies in implementing locative technologies to track missing individuals and develop programs that enhance safety and facilitate rescues, ultimately ensuring the well-being of vulnerable populations.

The National Institute on Aging (NIA) is inviting applications for the Alzheimer's Drug-Development Program (U01 Clinical Trial Optional). This initiative seeks to support pre-clinical and early-stage clinical development of innovative drug candidates aimed at preventing Alzheimer's disease or treating its symptoms. The program encourages collaboration among researchers and aims to enhance the therapeutic pipeline for AD through targeted approaches. This notice allows potential applicants time to prepare robust projects.

Research institutions and organizations conducting Alzheimer’s and dementia genetics research, including those in the Virgin Islands, can apply for U24 funding to build and operate a secure, cloud-based data platform. Grants from NIH help support NIAGADS by enabling large-scale AD/ADRD data ingestion, analysis, interoperability, and user training for the global research community.

Research institutions studying human consciousness and related neurologic conditions, including dementia and Alzheimer’s disease, in the Virgin Islands and other U.S. territories can apply for grants up to US $600,000. Focused on foundational neuroscience, the National Institutes of Health supports a national network developing shared standards, infrastructure, and training to advance this research.

Research institutions and teams studying Alzheimer’s disease-related dementias in the Virgin Islands can apply for National Institutes of Health funding to conduct comprehensive functional validation of new therapeutic targets. This phased support helps develop and test technologies, models, and protocols to rigorously assess target modulation and accelerate future translational research.

Researchers studying how environmental and neural exposome factors affect Alzheimer’s disease-related dementias can apply for National Institutes of Health support, including work in the Virgin Islands. National Institutes of Health supports mechanistic, translational, and human subjects research on exposomic contributions to ADRD pathology, progression, resilience, and neurological health disparities across the lifespan.

Research institutions and collaborative teams studying mechanisms of neurodegeneration in Alzheimer’s disease-related dementias can apply for National Institutes of Health Centers without Walls support, including work based in the Virgin Islands. Funding supports interdisciplinary consortia using advanced technologies, disease-relevant models, clinical science, and human specimens to uncover novel ADRD mechanisms, biomarkers, and therapeutic targets.

Researchers and research institutions studying Alzheimer’s disease and related dementias in the Virgin Islands can apply for upcoming National Institutes of Health U01 awards supporting preclinical target validation and early-stage drug discovery. This National Institute on Aging opportunity funds work on novel small molecules, biologics, and emerging therapeutic modalities for AD/ADRD treatment and prevention.

The Project Lifesaver International Grant by the Alzheimer’s Foundation of America aims to fund programs that prevent wandering and enhance public safety for individuals with dementia-related illnesses. This grant supports public safety agencies that are members of AFA and Project Lifesaver International, focusing on essential training, supplies, and community outreach. Grants are awarded biannually, promoting better care and safety for individuals living with Alzheimer’s disease and related dementias.

The Anne & Irving Brodsky Innovation Grant, offered by the Alzheimer's Foundation of America, provides $25,000 to support innovative programs that enhance the lives of individuals affected by Alzheimer's disease and related conditions. This grant is exclusively available to AFA nonprofit member organizations, with funding directed towards essential program expenses such as staff training, administrative costs, and necessary supplies. The initiative aims to foster advancements in care and support for families dealing with Alzheimer's.

The Alzheimer’s Association Clinician Scientist Fellowship for All (AACSFA) aims to support the training of clinician scientists in Alzheimer’s and other dementias. This program encourages applications from individuals in underrepresented groups, emphasizing the value of diverse representation in clinical and scientific fields. The fellowship is designed for professionals with patient contact or diagnostic roles, fostering advancements in dementia research and care.

The Milton & Phyllis Berg Family Respite Care Grants, offered by the Alzheimer’s Foundation of America, support member organizations in providing respite care scholarships to families affected by Alzheimer's. This initiative enhances the quality of life for both individuals and caregivers by promoting social engagement and offering essential breaks for caregivers. Grants are awarded biannually in memory of Barry E. Berg's parents, who faced Alzheimer's and caregiving challenges.

Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Program

The HSR-ADRD program seeks to support research that strengthens dementia detection, diagnosis, and post-diagnostic care pathways along the care continuum. Projects may address a range of health services research questions, including, but not limited to, studies examining barriers and solutions to timely access, quality, and care coordination. By supporting rigorous and innovative research, this program aims to generate actionable evidence to improve person-centered, coordinated, and equitable brain health and dementia care.

Program overview

The program welcomes proposals that utilize rigorous methodologies to advance understanding and improvement of cognitive impairment, including MCI and Alzheimer’s disease and related dementias (AD/ADRD) detection, diagnosis, and post-diagnostic care.

This award is structured as an individual research grant, with funding administered through the recipient’s institution. Proposals should address one or more Areas of Focus. Areas of Focus represent high-priority research topics for which this program is actively seeking proposals and include: 

• The Value of Early Detection and Diagnosis: Studies should investigate outcomes associated with early detection and diagnosis on at least two levels of the dementia care ecosystem (i.e., individual/families, providers/clinicians, health systems/payers, and policy/society).
• Care Pathways for Individuals with MCI or Dementia: Studies should consider comorbidities and investigate how people are being screened and diagnosed in different settings, and the post-diagnosis pathways for care and treatment, including pharmacological and non-pharmacological interventions or combinations thereof.

Funding overview

• Each HSR-ADRD award is limited to a total of $250,000 U.S. (direct and indirect costs) for a duration of up to two years (awards should be a minimum one year).
• Indirect costs are capped at 10 percent of total direct costs and are inclusive of indirect costs for the implementing institution as well as for any subcontracts.

The Alzheimer’s Association and ASNR Imaging Research Grant focuses on advancing imaging research in Alzheimer’s and other neurodegenerative diseases. This partnership aims to support early-stage pilot projects that develop novel imaging tools and innovative data analysis methods. Up to three proposals will be funded, with each award capped at $200,000 for one year, promoting significant advancements in the field and enhancing research capabilities for better understanding of dementia.

The Alzheimer’s Association Research Fellowship for All (AARFA) Program aims to support early career researchers dedicated to advancing the understanding and treatment of Alzheimer’s and other dementias. By providing funding to postdoctoral researchers under established mentorship, the program fosters the development of independent scientists. It encourages applications from individuals in underrepresented groups, recognizing the value of diverse perspectives in scientific inquiry and clinical practice, ultimately contributing to the fight against dementia.

The Dementia Care and Brain Degenerative Diseases Grant, offered by the Sephardic Home For The Aged Foundation, aims to support innovative projects enhancing care and quality of life for older adults affected by dementia. Eligible organizations must be 501(c)3 nonprofits in operation for at least two years. The Foundation prioritizes proposals focusing on dementia care, promoting collaboration and resource access for aging individuals. Interested applicants should submit a Letter of Inquiry through the online application system.

The Alzheimer’s Association Research Grant For All (AARGA) Program supports early-career investigators in their first seven years as independent researchers. This grant aims to fund projects that develop preliminary data and test new hypotheses in Alzheimer’s and related dementia research. Areas of interest include disease mechanisms, biomarker development, and health equity. Applications are welcome from both U.S. and international researchers, fostering innovation and collaboration in the fight against dementia.